PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-24.09%
Cash & equivalents declining -24.09% while Healthcare shows 0.00% growth. Howard Marks would investigate if this cash drain is temporary or signals deeper issues.
No Data
No Data available this quarter, please select a different quarter.
-24.09%
Cash + STI yoy growth ≥ 1.5x the Healthcare median of -1.81%. Joel Greenblatt would see a liquidity advantage if effectively redeployed.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.04%
Current assets growth ≥ 1.5x the Healthcare median of -0.65%. Joel Greenblatt sees a potential liquidity edge if well allocated.
-17.11%
PP&E growth below half of Healthcare median of 0.00%. Jim Chanos would suspect potential underinvestment or strategic shift away from core assets.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.78%
Below half the Healthcare median of 0.00%. Jim Chanos sees a sharp divergence from peers, possibly a sign of strategic retreat or capital shortage.
No Data
No Data available this quarter, please select a different quarter.
-19.98%
Below half the Healthcare median of 0.00%. Jim Chanos might see potential stagnation or distress vs. peers.
86.42%
Payables growth above 1.5x Healthcare median of 0.00%. Jim Chanos might see a warning sign of stressed supplier payments.
-100.00%
Above 1.5x Healthcare median of 0.00%. Jim Chanos might see a short-term leverage spike, raising red flags for near-term solvency.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Below half Healthcare median of 0.00%. Jim Chanos sees a potential sales pipeline shortfall.
-55.20%
Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a potential short-term burden spike.
21.67%
Above 1.5x Healthcare median of 1.87%. Jim Chanos suspects potential working capital strain.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
21.67%
Above 1.5x Healthcare median of 0.87%. Jim Chanos suspects an alarming rise in overall leverage.
0.96%
Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects heavier share issuance than peers.
-5.35%
≥ 1.5x Healthcare median of -1.10%. Joel Greenblatt sees stronger retained profit growth vs. peers.
-15.38%
Above 1.5x Healthcare median 0.00%. Jim Chanos suspects a red flag if these gains are highly volatile.
No Data
No Data available this quarter, please select a different quarter.
-25.41%
Below half Healthcare median of 0.00%. Jim Chanos suspects slower net worth growth or losses vs. peers.
-19.98%
Below half Healthcare median of 0.00%. Jim Chanos suspects a major slowdown or distress.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a big rise in leverage. Check coverage carefully.
23.76%
Above 1.5x Healthcare median 0.13%. Jim Chanos sees a big jump in net debt. Potential leverage red flag.